The global breast cancer diagnosis market is evaluated at US$4.713 billion for the year 2019 and is projected to grow at a CAGR of 5.11% to reach the market size of US$6.680 billion by the year 2026. Technological headways, such as the presentation of hybrid imaging methods are expected to expand the market development in the coming years.